Robocath Logo

Innovative Robotic Technology for Interventional Cardiology & Neurointervention

Robocath®, a wholly owned subsidiary of Stereotaxis, is a global leader in developing advanced robotic technology for endovascular interventions. We are pioneering a future where minimally-invasive treatment of stroke and cardiovascular diseases is enhanced by robotic precision and safety, automation and intelligence, and long-distance telesurgery.

Robocath system in procedure
r-one+ logo
Robocath primary robotic unit

Discover Robotic PCI

R-One+™, CE Marked and in clinical use at leading hospitals, is a robotic system for the precise control of endovascular wires and catheters during interventional procedures. By enhancing the manipulation of interventional devices, the system is designed to improve navigational accuracy, streamline workflow, and reduce radiation exposure and physical strain, allowing physicians to focus on delivering the best possible patient care.

Robotic Precision & Stability

R-One+ enhances procedural precision and stability through millimetric, motorized control of devices, supporting accurate lesion crossing and stent placement.

Radiation Reduction

Reduce radiation exposure by controlling interventional devices remotely from the control room. Studies show an 84% reduction in physician radiation exposure.*

* Durand E., Sabatier R., Smits PC., Verheye S., Pereira B., Fajadet J., Evaluation of the R-One robotic system for percutaneous coronary intervention: the R-EVOLUTION study, 2023, 10.4244/EIJ-D-22-00642

Easy to Use

Intuitive to use with a joystick control unit. Rapid to set up with devices easily loaded, exchanged and removed.

Plug & Play Solution

R-One+ is compatible with most leading guidewires, balloon catheters, stents, and imaging systems. Installs in minutes and integrates effortlessly into existing cath lab workflows.

Robotic Precision & Stability

R-One+ enhances procedural precision and stability through millimetric, motorized control of devices, supporting accurate lesion crossing and stent placement.

Radiation Reduction

Reduce radiation exposure by controlling interventional devices remotely from the control room. Studies show an 84% reduction in physician radiation exposure.*

* Durand E., Sabatier R., Smits PC., Verheye S., Pereira B., Fajadet J., Evaluation of the R-One robotic system for percutaneous coronary intervention: the R-EVOLUTION study, 2023, 10.4244/EIJ-D-22-00642

Easy to Use

Intuitive to use with a joystick control unit. Rapid to set up with devices easily loaded, exchanged and removed.

Plug & Play Solution

R-One+ is compatible with most leading guidewires, balloon catheters, stents, and imaging systems. Installs in minutes and integrates effortlessly into existing cath lab workflows.

The R-One+ System

R-One+ is comprised of a bedside robotic unit and remote control station.

The R-One+ System

R-One+ is comprised of a bedside robotic unit and remote control station.

Robocath system with part labels
Robocath system with part labels
Group of happy patients

Clinical Validation

Robocath technology has demonstrated clinical value across well-designed studies and robust, real-world commercial use at leading hospitals.

R-Evolution Study:

Evaluation of the R-One robotic system for percutaneous coronary intervention

Case Study: Bifurcation

Step-by-step case study of robotic complex coronary bifurcation procedure

Case Study: DCB

Step-by-step case study of robotic drug-coated balloon procedure

The Next Generation of Robotic Navigation

Driving Significant Innovation: Upcoming Robocath technology is taking robotic interventions to new heights with significant innovations…

Up to 5 Devices

Enabling simultaneous control and navigation of up to five independent interventional devices for even the most complex interventions.

Enhanced Modular Capability

Modular platform supporting both rapid-exchange and over-the-wire workflows.

Advanced Digital Suite

Advanced digital cockpit with seamless cath lab integration, TeleRobotic intervention, intelligent automation, and AI.

Join Us in Pioneering the Future

The Robocath Story

Founded in 2009 and based in Rouen, France, Robocath designs, develops and commercializes smart robotic solutions to treat cardiovascular diseases. Its mission is to pioneer robotics in the interventional cath lab in order to help physicians provide unsurpassed patient care with robotic precision and safety, expand access to minimally invasive therapy, and enhance the productivity, connectivity, and intelligence in the operating room.

The company received the CE marking for R-One, its first robotic solution, in 2019 following successful clinical outcomes in a prospective multicenter clinical trial. R-One systems are currently in use across Europe and China. Robocath was acquired by US-based robotics leader Stereotaxis in 2026 and serves as a fully-owned subsidiary of Stereotaxis.

year 2009

Robocath Founded

year 2013

First in Vivo Tests

year 2019

CE Mark & First-In-Man Procedures

year 2023

R-One+ Launch

year 2026

Aquired by Stereotaxis

Image of Robocath robotic system

Contact Us

Send us a message and our team will connect with you for more information.

19 rue Marie Curie, 76000 Rouen, France

LinkedIn Social Media Button
X Social Media Button
Youtube Social Media Button